Results 301 to 310 of about 636,444 (331)

Projecting the benefit of vericiguat in PARADIGM‐HF and DAPA‐HF populations: Insights from the VICTORIA trial

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1479-1484, April 2025.
Abstract Aims The VICTORIA trial demonstrated a significant reduction in the primary composite outcome of heart failure (HF) hospitalization or cardiovascular death with vericiguat relative to placebo in high‐risk HF. This study aimed to contextualize treatment effects of vericiguat in populations with varying risk profiles simulated from the PARADIGM ...
Veraprapas Kittipibul   +13 more
wiley   +1 more source

The risk factors of atrial substrate remodeling in the patients of paroxysmal atrial fibrillation following pulmonary vein isolation. [PDF]

open access: yesBMC Cardiovasc Disord
Ma JF   +9 more
europepmc   +1 more source

Identification of Proactive Health Behavior Clusters in Atrial Fibrillation-Related Ischemic Stroke Patients: A Multi-Center Latent Class Analysis. [PDF]

open access: yesVasc Health Risk Manag
Guo L   +10 more
europepmc   +1 more source

Cardiac Mass, Bacteremia, and Embolic Stroke. [PDF]

open access: yesJACC Case Rep
Kieu NT   +9 more
europepmc   +1 more source

Prediction of atrial fibrillation admissions in arrhythmia naïve patients from structured electronic health record data. [PDF]

open access: yesBMC Med Inform Decis Mak
Gokhale T   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy